Hemolytic anemia and cancer

Cancer Treatment Reviews

Volumn 22, Issue 1, 1996, Pages 33-73

  Diehl, Louis F ^a   Bolan, Charles D ^a   Weiss, Raymond B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; AUTOANTIBODY; CHLORAMBUCIL; CISPLATIN; CLADRIBINE; CYCLOSPORIN; CYTARABINE; DANAZOL; DOXORUBICIN; FLUDARABINE; HEMOGLOBIN H; IMMUNOGLOBULIN; MITOMYCIN; PREDNISONE; PYRUVATE KINASE; RECOMBINANT GAMMA INTERFERON; STEROID; TIOGUANINE; VINBLASTINE;

AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW TRANSPLANTATION; CANCER; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; ERYTHROCYTE; HEMOGLOBINOPATHY; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERSPLENISM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY INJURY; LEUKEMIA; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW; SPLENECTOMY; STOMACH CANCER; SURVIVAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM;

EID: 0030013844     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(96)90015-8     Document Type: Article

References (298)

1. Bull, B. S., Rubenberg, M. L., Dacie, J. V. & Brain, M. C. (1968) Microangiopathic haemolytic anaemia: mechanisms of red-cell fragmentation: in vitro studies. Br. J. Haematol. 14: 643-652.
2. Brain, M. C., Dacie, J. V. & Hourihane, D. O'B. (1962) Microangiopathic haemolytic anaemia: the possible role of vascular lesions in pathogenesis. Br. J. Haemat. 8: 358-374.
3. Antman, K. H., Skarin, A. T., Mayer, R. J., Hargreaves, H. K. & Canellos, G. P. (1979) Microangiopathic hemolytic anemia and cancer. A review. Medicine (Baltimore) 58: 377-384.
4. Lesesne, J. B., Rothschild, N., Erickson, B., Korec, S., Sisk, R., Keller, J., Arbus, M., Woolley, P. V., Chiazze, L., Schein, P.S. & Neefe, J. R. (1989) Cancer-associated hemolytic-uremic syndrome. Analysis of 85 cases from a national registry. J. Clin. Oncol. 17: 781-789.
5. Verwey, J., DeVries, J., Pinedo, H. M. (1987) Mitomycin C-induced renal toxicity, a dose-dependent side effect? Eur. J. Cancer Clin. Oncol. 23: 195-199.
6. Rauch, A. E., Tartaglia, A. P., Kaufman, B. & Kausel, H. (1984) RBC fragmentation and thymoma. Arch. Intern. Med. 144: 1280-1282.
7. Kressel, B. R., Ryan, K. P., Duong, A. T., Berenberg, J. & Schein, P. S. (1981) Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma. Cancer 48: 1738-1745.
8. Cantrell, J. E., Phillips, T. M. & Schein, P. S. (1985) Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J. Clin. Oncol. 3: 723-734.
9. Podzamczer, D., Carreras, L., Condom, E., Baucells J. M. & Vidaller, A. (1985) Microangiopathic hemolytic anemia associated with pulmonary adenocarcinoma. JAMA 254: 2554-2555.
10. Waldhorn, R. E., Tsou, E., Smith, F. P. & Kerwin, D. M. (1984) Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma. Med. Pediatr. Oncol. 12: 394-396.
11. Walker, R. W., Rosenblum, M. K., Kempin, S. J. & Christian, M. C. (1989) Carboplatin-associated thrombotic microangiopathic hemolytic anemia. Cancer 64: 1017-1020.
12. Milford, D. V., Goldstein, A., Barrett, M., Mann, J. R. & Raafat, F. (1993) Cancer associated haemolytic uraemic syndrome developing prior to treatment with cytotoxic agents. Med. Pediatr. Oncol. 21: 142-145.
13. Valvaara, R. & Nordman, E. (1985) Renal complications of mitomycin C therapy with special reference to the total dose. Cancer 55: 47-50.
14. Liel, Y. & Ariad, S. (1988) Microangiopathic hemolytic anemia associated with metastatic carcinoma of the colon. South Med. J. 81: 1320-1321.
15. McCarthy, J. T. & Staats, B. A. (1986) Pulmonary hypertension, hemolytic anemia, and renal failure: A mitomycin-associated syndrome. Chest 89: 608-611.
16. Poch, E., Almirall, J., Nicolas, J. M., Torras, A. & Revert, L. (1990) Treatment of Mitomycin-C associated hemolytic uremic syndrome with plasmapheresis. Nephron 55: 89-90.
17. Price, T. M., Murgo, A. J., Keveney, J. J., Miller-Hardy, D. & Kasprisin, D. O. (1985) Renal failure and hemolytic anemia associated with mitomycin C. A case report. Cancer 55: 51-56.
18. Garibotto, G., Acquarone, N., Saffioti, S., Deferrari, G., Villaggio, B. & Ferrario, F. (1989) Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis. Nephron 51: 409-412.
19. Pavy, M. D., Wiley, E. L. & Abeloff, M. D. (1982) Hemolytic-uremic syndrome associated with mitomycin therapy. Cancer Treat. Rep. 66: 457-461.
20. Giroux, L. Bettez, P. & Giroux, L. (1985) Mitomycin-C nephrotoxicity. A clinico-pathologic study of 17 cases. Am. J. Kidney Dis. 6: 28-39.
21. Milutinovic, J., Irby, S. & Fisher, M. (1982) Hemolytic uremic syndrome and metastatic malignancy. South Med. J. 75: 1409-1411.
22. Jackson, A. M., Rose, B. D., Graff, L. G., Jacobs, J. B., Schwartz, J. H., Strauss, G. M., Yang, J. P. S., Rudnick, M. R., Elfenbein, I. B. & Nairns, R. G. (1984) Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann. Intern. Med. 101: 41-44.
23. Sennesael, J. J., Vanden Houte, K. M., Spapen, H. D., de Bruyne, R. M. G. & Verbeelen, D. (1987) Recurrent hemolytic uremic syndrome and metastatic malignancy. Am. J. Nephrol. 7: 60-64.
24. Proia, A. D., Harden, E. A. & Silberman, H. R. (1984) Mitomycin-induced hemolytic-uremic syndrome. Arch. Pathol. Lab. Med. 108: 959-962.
25. Eugene, M., Deray, G., Cacoub, P., Achour, A. & Baumelou, A. (1987) Hemolytic uremic syndrome and prostate adenocarcinoma. Clin. Neph. 27: 46.
26. Hanna, W. T., Krauss, S., Regester, R. F., Murphy, W. M. (1981) Renal disease after mitomycin C therapy. Cancer 48: 2583-2588.
27. Gulati, S. C., Sordillo, P., Kempin, S., Reich, L., Magill, G. B., Scheiner, E. & Clarkson, B. (1980) Microangiopathic hemolytic anemia observed after treatment of epidermoid carcinoma with Mitomycin C and 5-Fluorouracil. Cancer 45: 2252-2557.
28. Farha, A. J. & Krauss, D. J. (1989) Renal failure after intravesical mitomycin C. Urology 34: 216-217.
29. Poch, E., Gonzalez-Clemente, J. M., Torras, A., Darnell, A., Botey, A. & Revert, L (1990) Silent renal microangiopathy after Mitomycin C therapy. Am. J. Nephrol. 10: 514-517.
30. Sheldon, R. & Slaughter, D. (1986) A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Cancer 58: 1428-1436.
31. Jao, W. & Manaligod, J. R. (1983) Renal disease associated with mitomycin therapy. Ultrastruc. Pathol. 5: 83-88.
32. Hamner, R. W., Verani, R. & Weinman, E. J. (1983) Mitomycin-associated renal failure: Case report and review. Arch. Intern. Med. 143: 803-807.
33. Lyman, N. W., Michaelson, R., Viscuso, R. L., Winn, R., Mulgaonkar, S. & Jacobs, M. G. (1983) Mitomycin-induced hemolytic-uremic syndrome: successful treatment with corticosteroids and intense plasma exchange. Arch. Intern. Med. 143: 1617-1618.
34. Jones, B. G., Fielding, J. W., Newman, C. E., Howell, A. & Brookes, V. S. (1980) Intravascular haemolysis and renal impairment after blood transfusion in two patients on long-term 5-fluorouracil and mitomycin-C. Lancet 1: 1275-1277.
35. Rumpf, W. K., Rieger, J., Lankisch, P. G., von Heyden, H. W., Nagel, G. A. & Scheler, F. (1980) Mitomycin induced haemolysis and renal failure. Lancet 2: 1037-1038.
36. Lempert, K. D. (1980) Haemolysis and renal impairment syndrome in patients on 5-fluorouracil and mitomycin C. Lancet 2: 369-370.
37. Torra, R., Poch, E., Torras, A., Bombi, J. A. & Revert, L. (1993) Pulmonary hemorrhage as a clinical manifestation of hemolytic-uremic syndrome associated with mitomycin C therapy. Chemotherapy 39: 453-456.
38. Karlin, D. A. & Stroehlein, J. R. (1980) Rash, nephritis, hypertension and haemolysis in patient on 5-fluoruracil, doxorubicin, and mitomycin-C. Lancet 2: 534-535.
39. Liu, K., Mittelman, A., Sproul, F. E. & Elias, E. G. (1971) Renal toxicity in man treated with mitomycin C. Cancer 28: 1314-1320.
40. Laffay, D. L., Tubbs, R. R., Valenzuela, R., Hall, P. M. & McCormack, L. J. (1979) Chronic glomerular microangiopathy and metastatic carcinoma. Hum. Pathol. 10: 433-438.
41. Montes, A., Powles, T. J., O'Brien, M. E. R., Ashley, S. E., Luckit, J. & Treleaven, J. (1993) A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome. Eur. J. Cancer 29A: 1854-1857.
42. Ravikumar, T. S., Sibley, R., Reed, K. & Grage, T. B. (1984) Renal toxicity of mitomycin-C. Am. J. Clin. Oncol. 7: 279-285.
43. Verwey, J., Boven, E., van der Meulen, J. & Pinedo, H. M. (1984) Recovery from mitomycin C-induced hemolytic uremic syndrome: A case report. Cancer 54: 2878-2881.
44. Mergenthaler, H. G., Binsack, T. & Wilmanns, W. (1988) Carcinoma-associated hemolytic uremic syndrome in a patient receiving 5-fluoruracil adriamycin mitomycin C combination chemotherapy. Oncol. 45: 11-14.
45. Loprinzi, C. L. (1984) Mitomycin C-induced pulmonary and renal toxicities. Wis. Med. J. 83: 16-17.
46. Boven, C. L. & Pinedo, H. M. (1983) Mitomycin C: interstitial pneumonitis and haemolytic uraemic syndrome: A report of two cases and review of the literature. Neth. J. Med. 26: 153-156.
47. van der Meer, J., de Vries, E. G. E., Vriesendorp, R., Willemse, P. H. B., Donker, A. J. M. & Aalders, J. G. (1985) Hemolytic uremic syndrome in a patient on cis-platinum, vinblastine and bleomycin. J. Cancer Res. Clin. Oncol. 110: 119-122.
48. Ratanatharathon, V., Baker, L. H. & Cadnapaphornchai, P. (1979). Clinical and pathologic study of mitomycin C nephrotoxicity. In: Carter, S. K., Crooke, S. T., eds, Mitomycin C, Current Status and New Developments. New York, Academic Press, p. 219.
49. Fielding, J. W. L., Fogg, S. L. & Jones, B. G. (1983) An interim report of a prospective randomized controlled study of adjuvant chemotherapy in operable gastric cancer. British Stomach Cancer Group. World J. Surg. 7: 390-399.
50. Mentzer, W. C., Baehner, R. L., Schmidt-Schoenbein, H., Robinson, S. H. & Nathan, D. G. (1971) Selective reticulocyte destruction in erythrocyte pyruvate-kinase deficiency. J. Clin. Invest. 50: 688-699.
51. Auclair, C., Dhermy, D. & Boivin, P. (1980) Superoxide dismutase deficiency in patients with nitrogen mustard therapy-induced intravascular hemolysis. Cancer Chemother. Pharmacol. 4: 281-282.
52. Dreyfus, B., Sultan, C., Rochant, H., Salmon, C., Mannoni, P., Cartron, J. P., Boivin, P. & Galand, C. (1969) Anomalies of blood group antigens and erythrocyte enzymes in two types of chronic refractory anaemia. Br. J. Haematol. 16: 303-312.
53. Valentine, W. N., Konrad, P. N. & Paglia, D. E. (1973) Dyserythropoiesis, refractory anemia, and 'preleukemia'. Metabolic features of the erythrocytes. Blood 41: 857-875.
54. Boivin, P., Galand, C., Hakim, J. & Kahn, A. (1975) Acquired erythroenzymopathies in blood disorders. Study of 200 cases. Br. J. Haematol. 31: 531-543.
55. Kahn, A., Cottreau, D., Boyer, C., Marie, J., Galand, C. & Boivin, P. (1976) Causal mechanisms of multiple acquired red cell enzyme defects in a patient with acquired dyserythropoiesis. Blood 48: 653-662.
56. Kornberg, A. & Goldfarb, A. (1986) Preleukemia manifested by hemolytic anemia with pyruvatekinase deficiency. Arch. Intern. Med. 146: 785-786.
57. Boivin, P., Galand, C., Audollent, M. (1970) Erythroenzymopathies acquises. 1. Anomalies quantitatives observees dans 100 cas d'hemopathies diverses. Pathol. Biol. 18: 175-187.
58. Yoo, D., Schlechter, G. P., Amigable, A. N. & Nienhuis, A. W. (1980) Myleoproliferative syndrome with sideroblastic anemia and acquired hemoglobin H disease. Cancer 45: 78-83.
59. Weatherall, D. J., Longlex, O. J., Wood, W. G., Clegg, J. B., Pollock, A. & Lewis, M. J. (1978) Acquired haemoglobin H disease in leukaemia. Pathophysiology and molecular basis. Br. J. Haematol. 38: 305-322.
60. Anagnou N. P., Ley, T. J., Chesbro, B., Wright, G., Kitchens, C., Liebhaber, S., Nienhuis, A. W. & Deisseroth, A. B. (1983) Acquired α-thalassemia in preleukemia is due to decreased expression of all four α-globin genes. Proc. Natl. Acad. Sci. USA 80: 6051-6055.
61. Higgs, D. R., Wood, W. G., Barton, C. & Weatherall, D. J. (1983) Clinical features and molecular analysis of acquired hemoglobin H disease. Am. J. Med. 75: 181-190.
62. Beaven, G. H., Stevens, B. L., Dance, N. & White, J. C. (1963) Occurrence of haemoglobin H in leukaemia. Nature 199: 1297-1298.
63. Boehme, W. M., Piira, T. A., Kurnick, J. E. & Bethlenfalvay, N. C. (1978) Acquired hemoglobin H in refractory sideroblastic anemia: a preleukemic marker. Arch. Intern. Med. 138: 603-606.
64. Hamilton, R. W., Schwartz, E., Atwater, J. & Erslev, A. J. (1971) Acquired hemoglobin H disease. N. Engl. J. Med. 285: 1217-1221.
65. White, J. C., Ellis, M., Coleman, P. N., Beaven, G. H., Gratzer, W. B., Shooter, E. M. & Skinner, E. R. (1960) An unstable haemoglobin associated with some cases of leukemia. Br. J. Haematol. 6: 171-177.
66. Old, J., Longley, J., Wood, W. G., Clegg, J. B. & Weatherall, D. J. (1977) Molecular basis for acquired haemoglobin H disease. Nature 269: 524-525.
67. Pagnier, J., Labie, D. & Schapira, G. (1973) Disturbed hemoglobin synthesis during erythroleukemia. Biochimie 55: 1245-1252.
68. Rosenzweig, A. I., Heywood, J. D., Motulsky, A. G. & Finch, C. A. (1968) Hemoglobin H as an acquired defect of alpha-chain synthesis. Report of two cases. Acta Haemat. 39: 91-101.
69. Pagnier, P. R, Labie, D., Kaplan, J. C., Junien, C., Najman, A. & Leroux, J. P. (1972) Etude biochimique d'un cas d'erythroleucemie. Nouv. Rev. Fr. D'Hemat. 12: 317-322.
70. Lindsey, R. J., Jackson, J. M. & Raven, J. L. (1978) Acquired haemoglobin H disease, complicating a myeloproliferative syndrome. A case report. Pathology 10: 329-334.
71. Doll, D. C. & Weiss, R. B. (1985) Neoplasia and the erythron. J. Clin. Oncol. 3: 429-446.
72. Reiner, A. P. & Spivak, J. L. (1987) Hematophagic histiocytosis: a report of 23 new patients and a review of the literature. Medicine (Baltimore) 67: 369-388.
73. Wong, K. F. & Chan, J. K. C. (1992) Reactive hemophagocytic syndrome - a clinicopathologic study of 40 patients in an oriental population. Am. J. Med. 93: 177-180.
74. Favara, B. E. (1992) Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin. Diag. Pathol. 9: 63-74.
75. Scott, R. B. & Robb-Smith, A. H. T. (1939) Histiocytic medullary reticulosis. Lancet 2: 194-198.
76. Warnke, R. A., Kim, H. & Dorfman, R. F. (1975) Malignant histiocytosis (histiocytic medullary reticulosis). I. Clinicopathologic study of 29 cases. Cancer 35: 215-230.
77. Jaffe, E. S., Costa, J., Fauci, A. S., Cossman, J. & Tsokos, M. (1983) Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am. J. Med. 75: 741-749.
78. Weiss, L. M., Trela, M. J., Cleary, M. L, Turner, R. R., Warnke, R. A. & Sklar, J. (1985) Frequent immunoglobulin and T-cell receptor gene rearrangements in 'histiocytic' neoplasms. Am J. Pathol 121: 369-373.
79. Falini, B., Pileri, S., De Solas, I., Martelli, M. F., Mason, D. Y., Delsol G., Gatter, K. C. & Fagioli, M. (1990) Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 75: 434-444.
80. Wilson, M.S., Weiss, L. M., Gatter, K. C., Mason, D. Y., Dorfman, R. F. & Warnke, R. A. (1990) Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 66: 530-536.
81. Franchino, C., Reich, C., Distenfeld, A., Ubriaco, A. & Knowles, D.M. (1988) A clinicopathologically distinctive primary splenic histiocytic neoplasm. Am. J. Surg. Pathol. 12: 398-404.
82. Ralfkiaer, E., Delsol, G., O'Connor, N.T. J., Brandztaeg, P., Brousset, P., Vejlsgaard, G. L. & Mason, D. Y. (1990) Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J. Pathol. 160: 9-17.
83. Weiss, L. M. (1992) Histiocytic and dendritic cell proliferations. In: Knowles, D. M., ed. Neoplastic Hematopathology. Baltimore, M.D., Williams and Wilkins, pp. 1480-1481.
84. Castoldi, G. Grusovin, G. D., Scapoli, G., Gualandi, M., Spanedda, R. & Anzanel, D. (1977) Acute myelomonocytic leukemia terminating in histiocytic medullary reticulosis. Cancer 40: 1735-1747.
85. Brynes, R. K., Golomb, H. M., Desser, R. K., Recant, W., Reese, C. & Rowley, J. (1976) Acute monocytic leukemia. Cytologic, histologic, cytochernical, ultrastructural, and cytogenetic observations. Am. J. Clin. Pathol. 65: 471-482.
86. Tubbs, R. R., Valenzuela, R., Savage, R. A. & Deodhar, S. D. (1979) The nature of surface immunoglobin in pure monocytic (M5) leukemia. Am. J. Clin. Pathol. 72: 614-617.
87. Wirt, D. P., Grogan, T. M., Payne, C. M., Kummet, T. D., Drurie, B. G. M., Finley, P. R. & Rollins, D. (1983) Phagocytic, lambda light chain, plasma cell myeloma. Am. J. Clin. Pathol. 80: 75-84.
88. Kadin, M. E., Kamoun, M. & Lamberg, J. (1981) Erythrophagocytic T-gamma lymphoma. A clinicopathologic entity resembling malignant histiocytosis. N. Engl. J. Med. 304: 648-653.
89. Schlimok, G., Thiel, E., Rieber, E. P., Huhn, D., Feucht, H., Renner, D. & Reithmuller, G. (1982) Proliferation of T-gamma lymphocytes in two patients. Clinical features and functional properties of the proliferating cells. Klin. Wochenschr. 60: 133-142.
90. Falini, B., Bucciarelli, E., Grignani, F. & Martelli, M. F. (1980) Erythrophagocytosis by undifferentiated lung carcinoma cells. Cancer 46: 1140-1145.
91. Marin-Padilla, M. (1977) Erythrophagocytosis by epithelial cells of a breast carcinoma. Cancer 39: 1085-1089.
92. Spivak, J. L (1973) Phagocytic tumour cells. Scand. J. Haematol. 11: 253-256.
93. Martelli, M. F., Falini, B., Tabilio, A., Velardi, A. & Rossodivita, M. (1980) Prolymphocytic leukaemia with erythrophagocytic activity. Br. J. Haematol. 46: 141-142.
94. Schechter, G. P., Guccion, J., Matthews, M., Fischman, A. B. & Bunn, P. A. (1981) Erythrophagocytic T-gamma lymphoma. N. Engl. J. Med. 305: 103-104.
95. Marton, P. F. (1975) Erythrophagocytosis in the human bone marrow as disclosed by iliac bone biopsies. Scand. J. Haematol. 14: 153-159.
96. Boxer, L. A., Greenberg, M. S., Boxer, G. J. & Stossel, T. P. (1975) Autoimmune neutropenia. N. Engl. J. Med. 293: 748-753.
97. Zinkham, W. H. & Diamond, L. K. (1952) In vitro erythrophagocytosis in acquired hemolytic anemia. Blood 8: 592-601.
98. Wheeler, M. S., Wilson, E. C. & Stass, S. A. (1980) Erythrophagocytosis by leukemia cells - a nonspecific finding. Am. J. Clin. Pathol. 75: 266-267.
99. Natelson, E. A., Lynch, E. C., Hettig, R. A. & Alfrey, C. P. (1968) Histiocytic medullary reticulosis. The role of phagocytosis in pancytopenia. Arch. Intern. Med 122: 223-229.
100. Lynch, E. C. & Alfrey, C. P. (1965) Histiocytic medullary reticulosis. Hemolytic anemia due to erythrophagocytosis by histiocytes. Ann. Intern. Med. 63: 666-671.
101. Johnston R. B. (1988) Monocytes and macrophages. N. Engl. J. Med. 318: 747-752.
102. Grossi, C. E., Webb, S. R., Zicca, A., Lydyard, P. M., Moretta, L & Mingari, M. C. (1978) Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG. J. Exp. Med. 147: 1405-1417.
103. Simrell, C. R., Margolick, J. B., Crabtree, G. R., Cossman, J., Fauci, A. S. & Jaffe, E. S. (1985) Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. Blood 65: 1469-1476.
104. Henter J.-I., Elinder, G., Soder, O., Hansson, M., Andersson, B. & Andersson, U. (1991) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78: 2918-2922.
105. Gaffey, M. J., Frierson, H. F., Medeiros, L. J. & Weiss, L. M. (1993) The relationship of Epstein-Barr virus to infection-related (sporadic) and familial hemophagocytic syndrome and secondary (lymphoma-related) hemophagocytosis: an in situ hybridization study. Hum. Pathol. 24: 657-667.
106. Gaillard, F., Mechinaud-LaCroix, F., Papin, S., Moreau, A., Mollat, C., Fiche, M., Peltier, S., De Faucal, P. J., Rousselet, M.-C., Praloran, V. & Harousseau, J.-L. (1992) Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am. J. Clin. Pathol. 98: 324-333.
107. Craig, F. E., Clare, C. N., Sklar, J. L. & Banks, P. M. (1992) T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am. J. Clin. Pathol. 97: 189-194.
108. Strumia, M. M. & Boerner, F. (1937) Phagocytic activity of circulating cells in the various types of leukemia. Am. J. Pathol. 13: 335-349.
109. Catovsky, D., Sperandio, P., O'Brien, M., Cherchi, M. & Galton, D. A. G. (1977) Phagocytic potential of leukaemic B-lymphocytes. Scand. J. Haematol. 19: 211-216.
110. Glasser, L (1980) Phagocytosis in acute leukemia. Cancer 45: 1365-1369.
111. Pui, C.-H., Mirro, J., Woodruff, L., Motroni, T. & Stass, S. (1986) Phagocytic activity and expression of myeloid-associated cell surface antigens by blast cells in acute lymphoblastic leukemia. Med. Pediatr. Oncol. 14: 12-16.
112. Shanley, J. D. & Cline, M. J. (1977) Phagocytosis of hematopoietic cells by blast cells in blast crisis of chronic myelocytic leukemia. West. J. Med. 126: 139-141.
113. Chen, T. K., Nesbit, M. E., McKenna, R. & Kersey, J. H. (1976) Histiocytic medullary reticulosis in acute lymphoblastic lymphoma of T cell origin. Am. J. Dis. Child. 130: 1262-1264.
114. Manoharan, A., Catovsky, D., Lampert, I. A., Al-Masadhani, Gordon-Smith, E. G. & Galton, D. A. G. (1981) Histiocytic medullary reticulosis complicating chronic lymphocytic leukemia: malignant or reactive? Scand. J. Haematol. 26: 5-13.
115. Okuda, T., Sakamoto, S., Deguchi, T., Misawa, S., Kashima, K., Yoshihara, T., Ikushima, S., Hibi, S. & Imashuku, S. (1991) Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am. J. Hematol. 38: 321-323.
116. Butterworth, C. E., Frommeyer, W. B. & Riser, W. H. (1953). Erythrophagocytosis in a case of plasma cell leukemia. Blood 8: 519-523.
117. Abramson, N., Kapff, C. V. & Ginsburg, A. D. (1970) The phagocytic plasma cells. N. Engl. J. Med. 283: 248.
118. Fitchen, J. H. & Lee, S. (1979) Phagocytic myeloma cells. Am. J. Clin. Pathol. 71: 722-723.
119. Raman, S., Frame, B., Saeed, S. M., Tolia, K., Raju, U. & Kottamasu, S. (1983) Diffuse nonsecretory osteosclerotic myeloma with extensive erythrophagocytosis. Am. J. Clin. Pathol. 80: 84-88.
120. Utsinger, P. D., Yount, W. J., Fuller, C. R., Logue, M. J. & Orringer, E. P. (1977) Hairy cell leukemia: B-lymphocyte and phagocytic properties. Blood 49: 19-27.
121. Wakefield, J. S. J. & Hicks, R. M. (1974) Erythrophagocytosis by the epithelial cells of the bladder. J. Cell Sci. 15: 555-573.
122. Molad, Y., Stark, P., Prokomicer, M., Joshua, H., Pinkhas, J. & Sidi, Y. (1991) Hemophagocytosis by small cell lung cancer. Am. J. Hematol. 36: 154-156.
123. Manoharan, A. & Painter, D. (1982) Histiocytic medullary reticulosis. Lancet 2: 881.
124. Korman, L. Y., Smith, J. R., Landaw, S. A. & Davey, F. R. (1979) Hodgkin's disease: intramedullary phagocytosis with pancytopenia. Ann. Intern. Med. 91: 60-61.
125. James, L. P., Stass, S. A., Peterson, V. & Schumacher, H. R. (1979) Abnormalities of bone marrow simulating histiocytic medullary reticulosis in a patient with gastric carcinoma. Am. J. Clin. Pathol. 71: 600-602.
126. Myers, T. J., Kessimian, N. & Schwartz, S. (1988) Mediastinal germ cell tumor associated with the hemophagocytic syndrome. Ann. Intern. Med. 109: 504-505.
127. Prokocimer, M., Inbal, A., Gelber, M., Shohat, Basat, M. B. & Shaklai, M. (1985) Hemophagocytosis simulating malignant histiocytosis: a terminal event of the myelodysplastic syndrome. Acta Haematol. 74: 164-167.
128. Wong, K. F., Chan, J. K. C., Ng, C. S., Chu, Y. C., Lam, P. W. Y. & Yuen, H. L (1991) Anaplastic large cell Ki-1 lymphoma involving bone marrow: marrow findings and association with reactive hemophagocytosis. Am. J. Hematol. 37: 112-119.
129. Diez-Martin, J. L., Lust, J. A., Witzig, T. E., Banks, P. M. & Li, C.-Y. (1991) Unusual presentation of extranodal peripheral T-cell lymphomas with multiple paraneoplastic features. Cancer 68: 834-841.
130. Ng, C.-S., Chan, J. K. C., Cheng, P. N. M. & Szeto, S.-C. (1986) Nasal T-cell lymphoma associated with hemophagocytic syndrome. Cancer 58: 67-71.
131. Chubachi, A., Imai, H., Nishimura, S., Saitoh, M. & Miura, A. B. (1992) Nasal T-cell lymphoma associated with hemophagocytic syndrome. Immunohistochemical and genotypic studies. Arch. Pathol. Lab. Med. 116: 1209-1212.
132. Economopoulos, T. C., Stathakis, N., Stathopoulos, E. & Alexopoulos, C. (1979) 'Lennert's lymphoma' terminating as malignant histiocytosis. Scand. J. Haematol. 23: 427-432.
133. Su, I.-J., Hsu, Y-H., Lin, M.-T, Cheng, A.-L., Wang, C.-H. & Weiss, L M. (1993) Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 72: 2019-2027.
134. Wick, M. R., Li, C.-Y., Ludwig, J., Levitt, R. & Pierre, R. V. (1980) Malignant histiocytosis as a terminal condition in chronic lymphocytic leukemia. Mayo Clin. Proc. 55: 108-112.
135. Kaplan, M. A., Jacobson, J. O., Ferry, J. A. & Harris, N. L. (1993) T-cell lymphoma of the vulva in a renal allograft recipient with associated hemophagocytosis. Am. J. Surg. Pathol. 17: 842-849.
136. Chan, J. K., Ng, C. S., Law, C. K., Ng, W. F. & Wong, K. F. (1987) Reactive hemophagocytic syndrome: a study of 7 fatal cases. Pathology 19: 43-50.
137. Cheng, A.-L, Su, I.-J., Chen, Y.-C., Uen, W.-C. & Wang, C.-H. (1993) Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer 72: 909-916.
138. Smith, K. J., Skelton, H. G., Giblin, W. L. & James, W. D. (1991) Cutaneous lesions of hemophagocytic syndrome in a patient with T-cell lymphoma and active Epstein-Barr infection. J. Am. Acad. Dermatol. 25: 919-924.
139. Griffin, J. D., Ellman, L., Long, J. C. & Dvorak, A. M. (1978) Development of a histiocytic medullary reticulosis-like syndrome during the course of acute lymphocytic leukemia. Am. J. Med. 64: 851-858.
140. Theodorakis M. K., Zamkoff, K. W., Davey, F. R., Ginsberg, S. J., Cass, D. L. & Gottlieb, A. J. (1983) Acute nonlymphocytic leukemia complicated by severe cytophagocytosis of formed blood elements by nonmalignant histiocytes: cause of significant clinical morbidity. Med. Pediatr. Oncol. 11: 20-26.
141. Starkie, C. M., Kenny, M. W., Mann, J. R., Cameron, A. H. & Hill, F. G. H. (1981) Histiocytic medullary reticulosis following acute lymphoblastic leukemia. Cancer 47: 537-544.
142. Goldman, J. M., Jacobson, B. M. & James, G. W. (1971) Splenectomy for histiocytic medullary reticulosis. Postgrad. Med. J. 47: 671-675.
143. Fort, D. W. & Buchanan, G. R. (1994) Treatment of infection associated hemophagocytic syndrome with immune globulin. J. Pediatr. 124: 332.
144. Gonzalez, C. L., Medeiros, L. J., Braziel, R. M. & Jaffe, E. S. (1991) T-cell lymphoma involving subcutaneous tissue. Am. J. Surg. Pathol. 15: 17-27.
145. Boyd, A. W., Ellis, D.W., Kannourakis, G., Begley, C. G., Mackay, I. R. & Burns, G. F. (1988) Activated killer cell lymphoma: an erythrophagocytic syndrome simulating histiocytic medullary histiocytosis. Pathology 20: 265-270.
146. (1993) Investigation of a positive DAT and immune hemolysis. In: Walker, R. H., ed. Technical Manual. Bethesda, MD: American Association of Blood Banks, p. 355.
147. Engelfriet, C. P., Overbeeke, M. A. M. & von dem Borne, A. E. G. K. (1992) Autoimmune hemolytic anemia. Semin. Hematol. 29: 3-12.
148. Dacie, J. V. & Worlledge, S. M. (1969) Auto-immune hemolytic anemias. Prog. Hematol. 6: 82-120.
149. (1980) Classification and clinical characteristics of autoimmune hemolytic anemias. In: Petz, L. D. & Garraty, G., eds. Acquired Immune Hemolytic Anemias. New York: Churchill Livingstone, pp. 26-63.
150. Gorst, D. W., Rawlinson, V. L., Merry, A. H. & Stratton, F. (1980) Positive direct antibody test in normal individuals. Vox. Sang. 38: 99-105.
151. Ness, P. M., Shirey, R. S., Thoman, S. K. & Buck, S. A. (1990) The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 30: 688-693.
152. Robertson, V. M., Dickson, L. G., Romond, E. H. & Ash, R. C. (1987) Positive antiglobulin tests due to intravenous immunoglobulin in patients who received bone marrow transplant. Transfusion 27: 28-31.
153. Heddle, N. M., Kelton, J. G., Turchyn, K. L. & Ali, M. A. M. (1988) Hypergammaglobinemia can be associated with a positive direct antiglobulin test, a non reactive eluate, and no evidence of hemolysis. Transfusion 28: 29-33.
154. Gilliand, B. C. (1976) Coombs-negative immune hemolytic anemia. Semin. Hematol. 13: 267-275.
155. Pirofsky, B. (1976) Clinical aspects of autoimmune hemolytic anemias. Semin. Hematol. 13: 251-265.
156. Kipps, T. J. & Carson, D. A. (1993) Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 81: 2475-2487.
157. Dameshek, W. & Schwartz, R. S. (1959) Leukemia and auto-immunization - some possible relationships. Blood 14: 1151-1158.
158. Lewis, F. B., Schwartz, R. S. & Dameshek, W. (1966) X-radiation and alkylating agents as possible 'trigger' mechanisms in the autoimmune complications of malignant lymphoproliferative disease. Clin. Exp. Immunol. 1: 3-11.
159. Dameshek, W. (1967) Chronic lymphocytic leukemia - an accumulative disease of immunologically incompetent lymphocytes. Blood 29: 566-584.
160. Pirofsky, B. (1968) Autoimmune hemolytic anemia and neoplasia of the reticuloendothelium. With a hypothesis concerning etiologic relationships. Ann. Intern. Med. 68: 109-121.
161. Nydegger, U. E., Kazatchkine, M. D. & Miescher, P. A. (1991) Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins. Semin. Hematol. 28: 66-77.
162. Pruzanski, W. & Shumak, K. H. (1977) Biologic activity of cold-reacting autoantibodies. (First of two parts). N. Engl. J. Med. 297: 538-542.
163. Pruzanski, W. & Shumak, K. H. (1977) Biologic activity of cold-reacting autoantibodies. (Second of two parts). N. Engl. J. Med. 297: 583-589.
164. Crisp, D. & Pruzanski, W. (1982) B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins). Am. J. Med. 72: 915-921.
165. Silberstein, L. E., Robertson, G. A., Harris, A. C. H., Moreau, L., Besa, E. & Nowell, P. C. (1986) Etiologic aspects of cold agglutinin disease: evidence for cytogenetically defined clones of lymphoid cells and the demonstration that an anti-Pr cold autoantibody is derived from a chromosomally aberrant B cell clone. Blood 67: 1705-1709.
166. Ritzmann, S. E. & Levin, W. C. (1962) Cold agglutinin disease. A type of primary macroglobulinemia: a new concept. Tex. Rep. Biol. Med. 20: 236-250.
167. Stewart, A. K. & Schwartz, R. S. (1994) Immunoglobulin V regions and the B cell. Blood 83: 1717-1730.
168. H4-21 segments. Blood 83: 2952-2961.
169. Dausset, J. & Colombani, J. (1959) The serology and the prognosis of 128 cases of autoimmune hemolytic anemia. Blood 14: 1280-1301.
170. Bell, C. A., Zwicker, H. & Sacks, H. J. (1973) Autoimmune hemolytic anemia: routine serologic evaluation in a general hospital population. Am. J. Clin. Pathol. 60: 903-911.
171. Sokol, R. J., Hewitt, S. & Stamps, B. K. (1981) Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre. BMJ 282: 2023-2027.
172. Hansen, M. M. (1973) Chronic lymphocytic leukemia. Clinical studies based on 189 cases followed for a long time. Scand. J. Haematol. 18 (Suppl.): 3-276.
173. Bartal, A., Bentwich, Z., Manny, N. & Izak, G. (1978) Ethnical and clinical aspects of chronic lymphocytic leukemia in Israel. A survey of 288 patients. Acta Haematol. 60: 161-171.
174. Seaman, A. J., Koler, R. D., Pirofsky, B. & Osgood, E. E. (1956) Incidence and treatment of acquired hemolytic anemia complicating chronic lymphocytic leukemia. Proceedings of the Sixth International Congress of the International Society of Hematology. Boston, MA, p. 857.
175. Robertson, T. I. (1990) Complications and causes of death in B cell chronic lymphocytic leukemia: a long term study of 105 patients. Aust. NZ J. Med. 20: 44-50.
176. Osgood, E. E. (1961) Antiglobulin-positive hemolytic anemias. Arch. Intern. Med. 107: 313-323.
177. Rosenthal, M. C., Pisciotta, A. V., Kominos, Z. D., Goldenberg, H. & Dameshek, W. (1954) The autoimmune hemolytic anemia of malignant lymphocytic disease. Blood 10: 197-227.
178. Pirofsky, B. (1969) Autoimmunization and the Autoimmune Hemolytic Anemias. Baltimore, MD: Williams and Wilkins.
179. De Rossi, G., Granati, L., Girelli, G., Gandolfo, G., Arista, M. C., Martelli, M., Conti, L., Marini, R., La Tagliata, R., Leone, R. & Mandelli, F. (1988) Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL). Nouv. Rev. Fr. Hematol. 30: 403-406.
180. Hamblin, T. J., Oscier, D. G. & Young, B. J. (1986) Autoimmunity in chronic lymphocytic leukemia. J. Clin. Pathol. 39: 713-716.
181. Eisner, E., Ley, A. B. & Mayer, K. (1967) Coombs'-positive hemolytic anemia in Hodgkin's disease. Ann. Intern. Med. 66: 258-273.
182. T. Transfusion 14: 226-231.
183. Levine, A. M., Thornton, P., Forman, S. J., Van Hale, P., Holdorf, D., Rouault, C. L., Powars, D., Feinstein, D. I. & Lukes, R. J. (1980) Positive Coombs' test in Hodgkin's disease: significance and clinical implications. Blood 55: 607-611.
184. Freedman, J., Cheng, L. F., Murray, D. & Myers, R. (1983) An unusual autoimmune hemolytic anemia in a patient with immunoblastic sarcoma. Am. J. Hematol. 14: 175-184.
185. Khumbanonda, M., Horowitz, H. I. & Eyster, M. E. (1969) Coombs' positive hemolytic anemia in myelofibrosis in myeloid metaplasia. Am. J. Med. Sci. 258: 89-93.
186. Huffman, R. & Silverstein, M. N. (1991) Agnogenic myeloid metaplasia. In: Huffman, R., Benz, E. J., Shattil, S. J., Furie, B. & Cohen, H. J., eds. Hematology, Basic Principles and Practice. New York: Churchill Livingstone, pp. 870-881.
187. Frizzera, G., Moran, E. M. & Rappaport, H. (1975) Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am. J. Med. 59: 803-818.
188. Jones, S. E. (1973) Autoimmune disorders and malignant lymphoma. Cancer 31: 1092-1098.
189. Shivdasani, R. A., Hess, J. L., Skarin, A. T. & Pinkus, G. S. (1993) Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. J. Clin. Oncol. 11: 802-811.
190. Spira, M. A. & Lynch, E. C. (1979) Autoimmune hemolytic anemia and carcinoma: an unusual association. Am. J. Med. 67: 753-758.
191. Frumin, A. M., Mendell, T. H. & Meranze, D. R. (1954) Hematologic manifestations of metastatic gastric malignancy. Gastroenterology 27: 183-188.
192. Hammond, D. B., Ellman, L. & Sirota, R. L. (1977) Kaposi's sarcoma presenting as autoimmune hemolytic anemia. Am. J. Hematol. 2: 393-396.
193. Rubinstein, I., Langevitz, P., Hirsch, R., Berkowicz, M. Lieberman, Y. & Shibi, G. (1985) Autoimmune hemolytic anemia as the presenting manifestation of malignant thymoma. Acta Haematol. 74: 40-42.
194. Gordon, P. A., Baylis, P. H. & Bird, G. W. G. (1976) Tumour-induced autoimmune haemolytic anaemia. BMJ 1: 1569-1570.
195. Ellis, L. D. & Westerman, M. P. (1965) Autoimmune hemolytic anemia and cancer. JAMA 193: 190-192.
196. Barry, K. G. & Crosby, W. H. (1957) Auto-immune hemolytic anemia arrested by removal of an ovarian teratoma: review of the literature and report of a case. Ann. Intern. Med. 47: 1002-1007.
197. Dawson, M. A., Talbert, W. & Yarbro, J. W. (1971) Hemolytic anemia associated with an ovarian tumor. Am. J. Med. 50: 552-556.
198. Bowdler, A. J. & Click, I. W. (1966) Autoimmune anemia as the herald state of Hodgkin's Disease. Ann. Intern. Med. 65: 761-767.
199. Bjorkholm, M., Holm, G. & Merk, K. (1982) Cyclic autoimmune hemolytic anemia as a presenting manifestation of splenic Hodgkin's Disease. Cancer 49: 1702-1704.
200. Dacie, J. V. (1967) The Haemolytic Anaemias. Congenital and Acquired. Part III - Secondary or Symptomatic Haemolytic Anaemias, Second edition. London: J. and A. Churchill, pp. 718-999.
201. Duhrsen, U., Augener, W., Zwingers, T. & Brittinger, G. (1987) Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. Br. J. Haematol. 67: 235-239.
202. Wasserman, L. R., Stats, D., Schwartz, L. & Fudenberg, H. (1955) Symptomatic and hemopathic hemolytic anemia. Am. J. Med. 18: 961-989.
203. Pisciotta, A. V. & Hirschboeck, J. S. (1957) Therapeutic considerations in chronic lymphocytic leukemia. Arch. Intern. Med. 99: 334-345.
204. Videbaek, A. (1960) Some clinical aspects of leukemia. Acta Haematol. 24: 54-58.
205. Kyle, R. A., Kiely, J. M. & Stickney, J. M. (1959) Acquired hemolytic anemia in chronic lymphocytic leukemia and the lymphomas. Survival and response to therapy in twenty-seven cases. Arch. Intern. Med. 104: 61-67.
206. Crosby, W. H. & Rappaport, H. (1956) Reticulocytopenia in autoimmune hemolytic anemia. Blood 11: 929-936.
207. Liesveld, J. L., Rowe, J. M. & Lichtman, M. A. (1986) Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood 69: 820-826.
208. Crosby, W. H. & Rappaport, H. (1956) Autoimmune hemolytic anemia. I. Analysis of hematologic observations with particular reference to their prognostic value. A survey of 57 cases. Blood 12: 42-55.
209. Rai, K. R. & Sawitsky, A. (1987) A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia. Blood Cells 12: 327-328.
210. Dameshek, W. & Kominos, Z. D. (1956) The present status of treatment of autoimmune hemolytic anemia with ACTH and cortisone. Blood 12: 648-664.
211. Ahn, Y. S., Harrington, W. J., Mylvaganam, R., Ayub, J. & Pall, L. M. (1985) Danazol therapy for autoimmune hemolytic anemia. Ann. Intern. Med. 102: 298-301.
212. Flores, G., Cunningham-Rundles, C., Newland, A. C. & Bussel, J. B. (1993) Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia. Am. J. Hematol. 44: 237-242.
213. Besa, E. C. (1988) Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. Am. J. Med. 84: 691-698.
214. Schwartz, R. & Dameshek, W. (1982) The treatment of autoimmune hemolytic anemia with 6-mercaptopurine and thioguanine. Blood 19: 483-500.
215. Hershko, C., Sonnenblick, M. & Ashkenazi, J. (1990). Control of steroid-resistant autoimmune haemolytic anemia by cyclosporine. Br. J. Haematol. 76: 436-437.
216. Kutti, J., Wadenvik, H., Safi-Kuti, S., Bjorkander, J., Hanson, L. A., Westberg, G., Johnsen, S.-A. & Larsson, B. (1984) Successful treatment of refractory autoimmune haemolytic anaemia by plasmapheresis. Scand. J. Haematol. 32: 149-152.
217. Besa, E. C., Ray, P. K., Swami, V. K., Idiculla, A., Rhoads, J. E., Bassett, J. G., Joseph, R. R. & Cooper, D. R. (1981) Specific immunoadsorption of IgG antibody in a patient with chronic lymphocytic leukemia and autoimmune hemolytic anemia. Am. J. Med. 71: 1035-1040.
218. Bowdler, A. J. (1976) The role of the spleen and splenectomy in autoimmune hemolytic disease. Semin. Hematol. 13: 335-348.
219. Harrington, W. J., Harrington, T. J. & Harrington, W. J. (1990) Is splenectomy an outmoded procedure? Adv. Intern. Med. 35: 415-440.
220. Djaldetti, M., De Vries, A. & Levie, B. (1962) Hemolytic anemia in lymphocytic leukemia. Treatment by irradiation of the spleen. Arch. Intern. Med. 110: 95-101.
221. Markus, H. & Forfar, J. C. (1986) Splenic irradiation in treating warm autoimmune haemolytic anaemia. BMJ 293: 839-840.
222. Salama, A., Berghofer, H. & Mueller-Eckhardt, C. (1992) Red blood cell transfusion in warm-type autoimmune haemolytic anemia. Lancet 340: 1515-1517.
223. Troup, S. B., Swisher, S. N. & Young, L. E. (1960). The anemia of leukemia. Am. J. Med. 28: 751-763.
224. Montserrat, E. & Rozman, C. (1993) Chronic lymphocytic leukemia treatment. Blood Rev. 7: 164-175.
225. DiRaimondo, F., Giustolisi, R., Cacciola, E., O'Brien, S., Kantarjian, H., Robertson, L. B. & Keating, M. J. (1992) Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk. Lymphoma 11: 63-68.
226. Piro, L. D., Carrera, C. J., Beutler, E. & Carson, D. A. (1988) 2-chlorodeoxyadenosine: an effective new agent in the treatment of chronic lymphocytic leukemia. Blood 72: 1069-1073.
227. Khouri, I. F., Keating, M. J., Vriesendorp, H. M., Reading, C. L., Przepiorka, D., Huh, Y. O., Andersson, B. S., van Besien, K. W., Mehra, R. C., Giralt, S. A., Ippoliti, C., Marshall, M., Thomas, M. W., O'Brien, S., Robertson, L E., Deisseroth, A. B. & Champlin, R. E. (1994) Autologous and allogeneic bone marrowtransplantation forchronic lymphocytic leukemia: preliminary results. J. Clin. Oncol. 12: 748-758.
228. Byrd, J., Weiss, R. B., Kweder, S. L & Diehl, L. F. (1994) Fludarabine therapy for lymphoid malignancies is associated with hemolytic anemia. Proc. Am. Soc. Clin. Oncol. 13: 991a.
229. Dimopoulos, M. A. & Alexanian, R. (1994) Waldenstrom's macroglobulinemia. Blood 83: 1452-1459.
230. Wortman, J., Rosse, W. & Logue, G. (1979) Cold agglutinin autoimmune hemolytic anemia in nonhematologic malignancies. Am. J. Hematol. 6: 275-283.
231. Isbister, J. P., Cooper, D.A., Blake, H. M., Biggs, J. C., Dixon, R. A. & Penny, R. (1978) Lymphoproliferative disease with IgM monoclonal protein and autoimmune hemolytic anemia. A report of four cases and review of the literature. Am. J. Med. 64: 434-440.
232. Gale, R., Smith, O. P., Wood, M. & Mehta, A. B. (1992) Splenic lymphoma with villous lymphocytes complicated by autoimmune haemolytic anemia. Lancet 340: 1106.
233. Sun, T., Susin, M., Brody, J., Dittmar, K., Teichberg, S., Weiner, R., Lin, J. H. & Felber, N. (1994) Splenic lymphoma with circulating villous lymphocytes: report of seven cases and review of the literature. Am. J. Hematol. 45: 39-50.
234. Getaz, E. P., Beckley, S., Fitzpatrick, J. & Dozier, A. (1984) Cisplatin-induced hemolysis. N. Engl. J. Med. 302: 334-335.
235. Levi, J. A., Aroney, R. S. & Dalley, D. N. (1981) Haemolytic anaemia after cisplatin treatment. BMJ 282: 2003-2004.
236. Manaka, R. C. & Wolf, W. (1978) Radiopharmacokinetic studies with PT-195m labelled cisplatin. J. Nucl. Med. 19: 732.
237. Zeger, G., Smith, L., McQuiston, D. & Goldfinger, D. (1988) Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells. Transfusion 28: 493-495.
238. Rabinowitz, A. P., Hu, E., Watkins, K. & Mazumder, A. (1990) Hemolytic anemia in a cancer patient treated with recombinant interferon-gamma. J. Biol. Response Mod. 9: 256-259.
239. Akard, L. P. & Elias, L. (1986) Alpha-interferon and immune hemolytic anemia. Ann. Intern. Med. 105: 306.
240. Quesada, J. R., Talpas, M., Rios, A. Durzrock, R. & Gutterman, J. U. (1986) Clinical toxicity of interferons in cancer patients. A review. J. Clin. Oncol. 4: 234-243.
241. Hui, K. S., Lichtiger, B. & Quesada, J. R. (1986) Cross-reactive red blood cell antigen-related substances in human leukocyte alpha interferon. Arch. Pathol. Lab. Med. 110: 128-130.
242. Cinollo, G., Dini, G., Franchini, E., Lanino, E., Sindaco, F. & Garaventa, A. (1988) Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin. Cancer Chemother. Pharmacol. 21: 85-86.
243. Harvey, M., Rosenfeld, D., Davies, D. & Hall, B. (1994) Recombinant interferon alpha and hemolytic uremic syndrome. Cause or coincidence. Am. J. Hematol. 46: 152-153.
244. Neville, A. J., Rand, C. A., Bar, R. D. & Mohan Pai, L. R. (1984) Drug-induced stomatocytosis and anemia during consolidation chemotherapy of childhood acute leukemia. Am. J. Med. Sci. 287: 3-7.
245. Barr, R. D., Davidson, A. R., Jung, L. K. L & Mohan Pai, K. R. (1980) Erythrocytoxicity induced by cancer chemotherapeutic agents. In vitro studies of osmotic fragility and methaemoglobin generation. Scand. J. Haematol. 25: 363-368.
246. Neville, A. J., Rand, C. A. & Barr, R. D. (1982) Vinblastine-induced erythrocytoxicity. Scand. J. Haematol. 28: 32-38.
247. Tosti, S., Caruso, R., D'Adamo, F., Picardi, A., Ali Ege, M., Girelli, G., Mauro, F. R., Maurillo, L. & Amadori, S. (1992) Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Ann. Hematol. 65: 238-239.
248. Keating, M. J. (1990) Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Semin. Oncol. 17: 49-62.
249. Cohn, J., Fraifeld, M., Desai, A. & Zaeri, N. (1994) Hemolytic uremic syndrome (HUS) and severe pulmonary toxicity associated with fludarabine treatment for non-Hodgkin's lymphoma (NHL). Proc. Am. Soc. Clin. Oncol. 13: 387.
250. Freymann, J. G., Burrell, S. B. & Marler, E. A. (1958) Role of hemolysis in anemia secondary to chronic lymphocytic leukemia and certain malignant lymphomas. N. Engl. J. Med. 259: 847-855.
251. Ludwin, D., Sacks, P., Synch, S., Jacobs, P., Bezwoda, W. & Bothwell, T. H. (1974) Auto-immune haematological complications occurring during the treatment of malignant lymphoproliferative diseases. South Afr. Med. J. 48: 2143-2145.
252. Thompson-Moya, L., Martin, T., Heuft, H. G., Neubauer, A. & Herrmann, R. (1989) Case Report: Allergic reaction with immune hemolytic anemia resulting from chlorambucil. Am. J. Hematol. 32: 230-231.
253. Powles, R. L., Clink, H. M., Spence, D., Morgenstern, G., Watson, J. G., Selby, P. J., Woods, M., Barrett, A., Jameson, B., Sloane, J., Lawler, S. D., Kay, H. E., Lawson, D., McElwain, T. J., & Alexander, P. (1980) Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1: 327-329.
254. Shulman, H., Striker, G., Deeg, H. J., Kenedy, M., Storb, R. & Thomas, E. D. (1981) Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: Glomerular thromboses and tubular injury. N. Engl. J. Med. 305: 1392-1395.
255. Marshall, R. J. & Sweny, P. (1986) Haemolytic uraemic syndrome in recipients of bone marrow transplants not treated with cyclosporin A. Histopathology 10: 953-962.
256. Chappell, M. E., Keeling, D. M., Prentice, H. G. & Sweny, P. (1988) Hemolytic uraemic syndrome after bone marrow transplantation. An adverse effect of total body irradiation? Bone Marrow Transplant 3: 339-347.
257. Guinan, E. C., Tarbell, N. J., Niemeyer, C. M., Sallan, S. E. & Weinstein, H. J. (1988) Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood 72: 451-455.
258. Juckett, M., Perry, E.H., Daniels, B. S. & Weisdorf, D. J. (1991) Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 7: 405-409.
259. Rabinowe, S. N., Soiffer, R. J., Tarbell, N.J., Neuberg, D., Freedman, A. S., Seifter, J., Blake, K. W., Gribben, J. G., Anderson, K. C., Takvorian, T., Ritz, J. & Nadler, L. M. (1991) Hemolyticuremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 77: 1837-1844.
260. Reece, D. E., Frei-Lahr, D. A., Shepherd, J. D., Dorovini-Zis, K., Gascoyne, R. D., Graeb, D. A., Spinelli, J. J., Barnett, M. J., Klingemann, H. G., Herzig, G. P. & Phillips, G. L (1991) Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 8: 393-401.
261. Neild, G. H., Rocchi, G., Imberti, L., Fumagalli, F., Brown, Z., Remuzzi, G. & Williams, D. G. (1983) Effect of Cyclosporine A on prostacyclin synthesis by vascular tissue. Thromb. Res. 32: 373-379.
262. Boogaerts, M. A., Tricot, G., Westelinck, K. & Verwilghen, R. L. (1978) Cyclosporin-syndrome post bone marrow transplantation: interference with vascular prostacyclin production. Blood 64 (suppl. 1): 210a.
263. Maddox, A. M., Verani, R. & Kahan, B. D. (1985) De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine. Surgery 98: 54-62.
264. Ueno, H., Ishiyama, T., Yamada, K., Akimoto, Y., Koike, M., Nakamaki, T., Hino, K., Tomoyasu, S. & Tsuruoka, N. (1993) Red cell fragmentation syndrome after bone marrow transplantation presumed to be caused by cyclosporin A. Rinsho Ketsueki 34: 362-366.
265. Hatta, Y., Tomura, K., Kawamura, M., Itoh, T., Baba, M. & Horie, T. (1992) Microangiopathic hemolytic anemia in a graft-versus-host disease patient treated with cyclosporine A and prednisolone. Intern Med. 31: 434-437.
266. Buckner, C. D., Clift, R. A., Sanders, J. E., Gray, W. M., Storb, G. R. & Thomas, E. D. (1978) ABO-incompatible marrow transplants. Transplantation 26: 233-238.
267. Bensinger, W. I., Buckner, C. D., Thomas, E. D., Clift, R. A. (1982) ABO-incompatible marrow transplants. Transplantation 33: 427-429.
268. Sniecinski, I. J., Oien, L., Petz, L. D. & Blume, K. G. (1988) Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 45: 530-534.
269. Barge, A. J., Johnson, G., Witherspoon, R. & Torok-Storb, B. (1989) Antibody-mediated marrow failure after allogeneic bone marrow transplantation. Blood 74: 1477-1480.
270. Gmur, J. P., Burger, J., Schaffner, A., Neftel, K., Oeiz, O., Frey, D. & Metaxas, M. (1990) Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 75: 290-295.
271. Klumpp, T. R., Caliguri, M. A., Rabinowe, S. N., Soiffer, R. J., Murray, C. & Ritz, J. (1990) Autoimmune pancytopenia following allogeneic bone marrow transplantation. Bone Marrow Transplant 6: 445-447.
272. Rosenfeld, C. S., Winters, S. J. & Tedrow, H. E. (1989) Diethylstilbestrol-associated hemolytic anemia with a positive direct antiglobulin test result. Am. J. Med. 86: 617-618.
273. Sandveli, P., Nordhagen, R., Michaelsen, T. E. & Wolthuis, K. (1987) Fluorouracil (5FU) induced acute immune haemolytic anaemia. Br. J. Haematol. 65: 357-359.
274. Bastion, Y., Coiffier, B., Dumonet, C., Espinouse, D. & Bryon, P. A. (1992) Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Ann. Oncol. 3: 171-172.
275. Weetman, R. M., Coates, T. D., Griep, J. A. & Riley, J. W. (1982) Asparaginase induced immune hemolytic anemia. Proc. Am. Soc. Clin. Oncol. 1: 25a.
276. Habibi, B., Lopes, M., Serdaru, M., Baumelou, A., Vonlanther, M., Marteau, R. & Salmon, C. (1982) Immune hemolytic anemia and renal failure due to teniposide. N. Engl. J. Med. 306: 1091-1093.
277. Eyster, M. E. (1967) Melphalan (alkeran) erythrocyte agglutinin and hemolytic anemia. Ann. Intern. Med. 66: 573-577.
278. Klumpp, T. R., Block, C. C., Caligiuri, M. A., Rabinowe, S. N., Soiffer, R. J. & Ritz, J. (1992) Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature. Medicine (Baltimore) 71: 73-83.
279. Pangalis, G. A. & Griva, E. (1988) Recombinant alpha-2b-interferon therapy in untreated, stages A and B chronic lymphocytic leukemia: A preliminary report. Cancer 61: 869-872.
280. Holler, E., Kolb, H. J., Hiller, E., Mraz, W., Lehmacher, W., Gleixner, B., Seeber, C., Jehn, U., Herhartz, H. H., Brehm, G. & Wilmanns, W. (1989) Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 73: 2018-2024.
281. Fisher, J. H., Welch, C. S. & Dameshek, W. (1952) Splenectomy in leukemia and leukosarcoma. N. Engl. J. Med. 246: 477-484.
282. Bowdler, A. J. (1983) Splenomegaly and hypersplenism. Clin. Haematol. 12: 467-488.
283. Sills, R. H. (1989) Hypersplenism. In Pochedly, C., Sills, R. H., Schwartz, A. D., eds. Disorders of the Spleen. Pathophysiology and Management. New York: Marcel Dekker, pp. 167-186.
284. Crosby, W. H. (1962) Hypersplenism. Ann. Rev. Med. 13: 127-146.
285. Crosby, W. H. (1972) Splenectomy in hematologic disorders. N. Engl. J. Med. 286: 1252-1254.
286. Christenson, B. E., Jonsson, V. & Videbaek, A. (1983) The spleen in lymphoproliferative disorders. Clin. Haematol. 12: 517-533.
287. Kiely, J. M. & Silverstein, M. N. (1969) Metastatic carcinoma simulating agnogenic myeloid metaplasia and myelofibrosis. Cancer 24: 1041-1044.
288. Christenson, B. E. (1973) Erythrocyte pooling and sequestration in enlarged spleens. Estimations of splenic erythrocyte and plasma volume in splenomegalic patients. Scand. J. Haematol. 10: 106-119.
289. Barrett, O., Panettiere, F., Cohen, A. (1970) Symptomatic hemolytic anemia in carcinoma. Cure with splenectomy. Arch. Surg. 100: 310-312.
290. Dunn, M. A., Goldwein, M. I. (1975) Hypersplenism in advanced breast cancer: report of a patient treated with splenectomy. Cancer 35: 1449-1452.
291. Grigg, A. P., Berean, K., Shore, T. & Phillips, G. L (1992) Pancytopenia due to hypersplenism after allogeneic bone marrow transplantation. Bone Marrow Transplant 10: 177-179.
292. Singh, A. K. (1992) A prospective study of the evolution of chronic lymphocytic leukemia. Leuk. Lymphoma 7: 87-97.
293. Stein, R. S., Weikert, D., Reynolds, V., Greer, J. P. & Flexner, J. M. (1987) Splenectomy for end-stage chronic lymphocytic leukemia. Cancer 59: 1815-1818.
294. Goldman, J. M. & Nolasco, I. (1983) The spleen in myeloproliferative disorders. Clin. Haematol. 12: 505.
295. Kehoe, J. E., Daly, J. M., Straus, D. J. & DeCosse, J. J. (1985) Value of splenectomy in non-Hodgkin's lymphoma. Cancer 55: 1256-1264.
296. Coad, J. E., Matutes, E. & Catovsky, D. (1993) Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literature. Leuk. Lymphoma 10: 245-264.
297. Danforth, D. N. & Fraker, D. L. (1991) Splenectomy for the massively enlarged spleen. Am. Surg. 57: 108-113.
298. Aabo, K., Walbom-Jorgensen, S. (1985) Spleen irradiation in chronic lymphocytic leukemia (CLL): palliation in patients unfit for splenectomy. Am. J. Hematol. 19: 177-180.